Takahashi, S., Sakamoto, Y., Denda, T., Takashima, A., Komatsu, Y., Nakamura, M., . . . Ishioka, C. (2021). Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer. Cancer science, 112(4), 1567-1578. https://doi.org/10.1111/cas.14841
Citace podle Chicago (17th ed.)Takahashi, Shin, et al. "Advanced Colorectal Cancer Subtypes (aCRCS) Help Select Oxaliplatin‐based or Irinotecan‐based Therapy for Colorectal Cancer." Cancer Science 112, no. 4 (2021): 1567-1578. https://doi.org/10.1111/cas.14841.
Citace podle MLA (9th ed.)Takahashi, Shin, et al. "Advanced Colorectal Cancer Subtypes (aCRCS) Help Select Oxaliplatin‐based or Irinotecan‐based Therapy for Colorectal Cancer." Cancer Science, vol. 112, no. 4, 2021, pp. 1567-1578, https://doi.org/10.1111/cas.14841.